Immunogenicity of alefacept seen as minimal

May 1, 2002

New Orleans - Following treatment with IV- or IM-administered alefacept (Amevive), more than 1,000 patients with chronic plaque psoriasis showed insignificant levels of drug-related antibody.

Related Content:

Pediatric Dermatology